Pennsaid 2% diclofenac regulatory update

Nuvo Research said Mallinckrodt completed a pharmacokinetic study requested by FDA in a March complete response letter for an NDA for Pennsaid 2% diclofenac sodium to treat osteoarthritis (OA) of the ...